Cargando…

Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19

Serum amyloid-A (SAA) is associated with inflammatory disorders such as rheumatoid arthritis, Familial Mediterranean Fever, sarcoidosis, and vasculitis. There is accumulating evidence that SAA is a reliable biomarker for these autoinflammatory and rheumatic diseases and may contribute to their patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almusalami, Eman M., Lockett, Anthony, Ferro, Albert, Posner, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060655/ https://www.ncbi.nlm.nih.gov/pubmed/37007776 http://dx.doi.org/10.3389/fmed.2023.1135695

Ejemplares similares

Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy
por: Qi, Peng, et al.
Publicado: (2023)

Increased ICU mortality in septic shock patients with hypo- or hyper- serum osmolarity: A retrospective study
por: Heng, Gang, et al.
Publicado: (2023)

Hyper-Eosinophilic Syndrome Masquerading as Myocardial Infarction, Stroke and Cancer
por: Minupuri, Arun, et al.
Publicado: (2020)

Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches
por: Choi, Hojun, et al.
Publicado: (2022)

Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions
por: den Hartigh, Laura J., et al.
Publicado: (2023)

Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review
por: Lan, Jun, et al.
Publicado: (2022)

Of the Use of Stimulants in Inflammatory Diseases of the Lungs in Children
por: Posner,
Publicado: (1845)

Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure
por: Parry, Traci L., et al.
Publicado: (2015)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
por: Qi, Xue-mei, et al.
Publicado: (2017)

Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome
por: Romano, Vito, et al.
Publicado: (2022)

Sirtuins as Potential Therapeutic Targets for Hepatitis B Virus Infection
por: Kong, Fanyun, et al.
Publicado: (2021)

Asymptomatic HyperCKemia: A Diagnostic Trap
por: Shaikh, Safia, et al.
Publicado: (2021)

Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk
por: Edwards, Nicola, et al.
Publicado: (2018)

Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets
por: Weidinger, Carl, et al.
Publicado: (2021)

The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

Coagulation Dysfunction in Acute Respiratory Distress Syndrome and Its Potential Impact in Inflammatory Subphenotypes
por: Livingstone, Samantha A., et al.
Publicado: (2021)

Can GPR4 Be a Potential Therapeutic Target for COVID-19?
por: Yang, Li V., et al.
Publicado: (2021)

Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review
por: La Rocca, Gaetano, et al.
Publicado: (2023)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Atypical Guillain-Barre Syndrome With a Sensory Level and Hyper-Acute Presentation: A Case Report
por: Kommu, Sharath, et al.
Publicado: (2023)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
por: Shah, Sajeel A., et al.
Publicado: (2017)

Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target
por: Wu, Maomao, et al.
Publicado: (2022)

Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery
por: Mishra, Abhinav P., et al.
Publicado: (2018)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
por: Dong, Xiaocheng Charlie
Publicado: (2019)

Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
por: Aramini, Beatrice, et al.
Publicado: (2023)

Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Hyper IgE syndrome
por: Dang, Yun, et al.
Publicado: (2014)

The Development of Serum Amyloid P as a Possible Therapeutic
por: Pilling, Darrell, et al.
Publicado: (2018)

APOE-amyloid interaction: Therapeutic targets
por: Wisniewski, Thomas, et al.
Publicado: (2020)

Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer
por: Zhang, Jiyan, et al.
Publicado: (2021)

Caveolin-1 in vascular health and glaucoma: A critical vascular regulator and potential therapeutic target
por: Loo, Jing Hong, et al.
Publicado: (2023)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Acute Sepsis-Induced Cholestatic Disease Presenting With Isolated Hyper-Bilirubinemia
por: Hossein-javaheri, Nariman, et al.
Publicado: (2023)

Sequential changes in hepatic mRNA abundance and serum concentration of serum amyloid A in cattle with acute inflammation caused by endotoxin
por: OTSUKA, Marina, et al.
Publicado: (2020)

The relationship between sleep and salivary and serum inflammatory biomarkers in adolescents
por: Alqaderi, Hend, et al.
Publicado: (2023)

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
por: Yoon, Sang-Sun, et al.
Publicado: (2012)

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
por: Choudhary, Gaurav S, et al.
Publicado: (2022)

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
por: Soares, Cleverson T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e0i4lu7372iko43ka6g0p32fct